Private
The U.S. Department of Energy (DOE) awarded funding on Thursday to the National Rural Electric Cooperative Association (NRECA) to advance the React cybersecurity solution for utilities that monitors IT networks for near real-time detection of possible cyber intrusions.
React will aim to develop... Read More »
Raytheon Company released a comprehensive plan to the U.S. Army on Monday for the next generation of air and missile defense radar.
The plan was released as part of a process to specifically define the requirements for a future lower tier air and missile defense sensor (LTAMDS).... Read More »
The U.S. Food and Drug Administration (FDA) recently approved Emergent BioSolutions, Inc.’s supplemental Biologics License Application (sBLA) for the manufacture of BioThrax (Anthrax Vaccine Adsorbed) at the company’s large-scale Building 55 manufacturing facility in Lansing,... Read More »
Soligenix, Inc., released information regarding its performance and accomplishments in the second quarter on Thursday.
“We continue to be very encouraged with the positive results demonstrated in our Phase 2 oral mucositis trial with SGX942 and expect to report long-term safety data during... Read More »
Blighter Surveillance Systems, Ltd., made two appointments on Wednesday to assist the company in targeting the oil, gas and petrochemical markets with its Blighter B400 Series e-scan doppler radar and long-range thermal camera surveillance solution.
The Blighter B400 doppler radar delivers... Read More »
Smiths Detection was awarded a contract on Wednesday by the Falcon Group worth approximately $24.5 million to provide advanced detection systems for passenger checkpoints, baggage screenings and cargo screenings for airports across Egypt.
Smiths will provide x-ray scanners, people-screening... Read More »
The U.S. Centers for Disease Control and Prevention (CDC) exercised a contract option with Emergent BioSolutions, Inc., on Tuesday valued at $11.6 million over a 12-month period for the supply of vaccinia immune globulin (VIGIV) to the U.S. Strategic National Stockpile (SNS).
The U.S. Food and... Read More »
ClinicalRM recently expanded access protocol with ZMapp, an investigational treatment for Ebola virus disease (EVD) in Africa and the United States.
ZMapp combines three monoclonal antibodies developed by Mapp Biopharmaceutical, Inc., and LeafBio, the commercialization arm of Mapp, to fight... Read More »
Hologic, Inc., entered into an agreement on Tuesday worth $4.1 million with the U.S. Department of Health and Human Services’ (HHS) Office of the Assistance Secretary for Preparedness and Response (ASPR) to advance the development of a blood screening test that will detect Zika virus.
The one... Read More »
SIGA Technologies, Inc., received approval on Tuesday from its data safety monitoring board (DSMB) to complete enrollment in the second and final cohort of healthy subjects for the Phase III clinical study of TPOXX for the treatment of orthopoxvirus infections.
The approval was based on a study... Read More »
A major gap in international standards for biosafety in laboratories handling contagious pathogens potentially increases the risk that an accident could result in a disease outbreak that threatens global security, according to a recent study by the UPMC Center for Health Security.
The year-long... Read More »
A team of researchers at the Lawrence Livermore National Laboratory (LLNL) recently developed a flexible material that is both highly breathable and protective from various biological agents that soldiers may come into contact with.
The material is the first key component of a new type of... Read More »
A disaster strikes a congested city, cell phone networks are overwhelmed and internet access is spotty. Nearly everyone has a mobile device in their pocket, but few can use them to communicate.
San Francisco-based start-up OpenGarden, Inc., has a solution to this type of crisis with its FireChat... Read More »
Deep Red, Raytheon Company’s team of cyber experts, is one of the featured teams competing in the Defense Advance Research Projects Agency (DARPA) Cyber Grand Challenge finals during the DEF CON conference this week.
DARPA began the Cyber Grand Challenge as a computer security tournament... Read More »
Altimmune, Inc., and the Biomedical Advanced Research and Development Authority (BARDA) are set to advance the first clinical trial later this month of an anthrax vaccine that could be administered in a single dose.
The trial was initiated from a two-year, $14 million contract between BARDA and... Read More »
The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a $5.1 million, two-year contract to InBios International, Inc., on Monday for a newer, faster Zika virus diagnostic blood test.
InBios’ test may have the... Read More »
The Defense Advanced Research Projects Agency (DARPA) will host the world’s first all-machine hacking tournament this week.
The Cyber Grand Challenge marks the culmination of an ambitious three-year effort to develop advanced, autonomous systems that can detect, evaluate and patch software... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) and the National Institute of Allergy and Infectious Diseases (NIAID) provided additional funding to Soligenix, Inc., this week to advance preclinical development of OrbeShield (oral beclomethasone 17,21-dipropionate or oral BDP) as... Read More »
U.S. Rep. Dan Donovan (R-NY) on Tuesday decried actions by his congressional colleagues for jeopardizing the development of a vaccine for the Zika virus.
Donovan’s statement came in the wake of three different companies threatening to halt their developments due to funding uncertainty.... Read More »
The International Criminal Police Organization (INTERPOL) produced its first biosafety curriculum for police colleges to advance law enforcement capability and preparedness in responding to biological incidents on Tuesday.
The initiative was developed under Project Rhino and seeks to address... Read More »
U.S. Sen. Jim Risch (R-ID), the chairman of the Energy and Natural Resources Subcommittee on Energy, chaired a hearing on the Securing Energy Infrastructure Act, S. 3018, and to examine protections designed to guard against energy disruptions last week.
“In the United States, we too often we... Read More »
Soligenix released positive preliminary proof-of-concept results on Monday from its collaboration with Axel Lehrer to develop a heat-stable subunit Ebola virus vaccine.
Lehrer is a doctor in the Department of Medicine, Medical Microbiology and Pharmacology at the John A. Burns School of... Read More »
Researchers at the Edgewood Chemical Biological Center (ECBC) and CBI Polymer recently explored how a HydroGel can be modified to decontaminate surfaces contaminated with harmful biological agents, such as the anthrax-inducing Bacillus anthracis.
HydroGel is a biosynthetic polymer that can be... Read More »
The National Institute of Allergy and Infectious Diseases (NIAID) provided BioCryst Pharmaceuticals with additional funding on Monday for efficacy studies of BCX4430 in non-human primates to further assist effective dose regimens.
BCX4430 is a broad-spectrum antiviral that is advancing toward... Read More »
An independent panel of public health, emergency response and communication experts issued a report on Friday on the Ebola epidemic of 2014, identifying recommendations to improve the U.S. Department of Health and Human Services (HHS) response to urgent public health threats.
Concerns... Read More »
The Partnership for Research on Ebola virus in Liberia (PREVAIL) on Monday opened PREVAIL IV, a treatment trial for men who have survived Ebola virus disease (EVD) but continue to have evidence of Ebola virus genetic material - RNA - in their semen.
The trial is sponsored by the National... Read More »
FLIR Systems acquired Armasight, Inc., a leading developer of precision sporting, hunting and military optics products, for approximately $41 million on Wednesday.
"The addition of Armasight to our existing scopes and sights business provides us with meaningful additional scale and injects... Read More »
The National Institutes of Allergy and Infectious Diseases (NIAID) released a report on Tuesday detailing how a single dose of either of two experimental Zika vaccines protected mice infected with the virus for four to eight weeks after receiving the inoculations.
NIAID said that this... Read More »
Lockheed Martin’s Q-53 counter fire radar last week demonstrated its ability to identify and track unmanned aerial systems (UAS) and pass that information to a command and control node.
Lockheed said that this capability will assist forces in a crowded battle space with emerging air threats.... Read More »
Emergent BioSolutions, Inc.’s Center for Innovation in Advanced Development and Manufacturing (CIADM) received a task order on Monday valued at up to $21.9 million from the Biomedical Advanced Research and Development Authority (BARDA) to develop and manufacture a Zika vaccine.
Three cGMP lots... Read More »
The National Institutes of Health (NIH), along with the scientific research organization Fundacao Oswaldo Cruz-Fiocruz, began a multi-country study on Tuesday to evaluate the magnitude of the health risks that Zika virus infection poses on pregnant women and their developing fetuses and infants.... Read More »
The U.S. Department of Health and Human Services (HHS) issued two solicitation notices on Tuesday related to the development and procurement of anthrax vaccines for the Strategic National Stockpile (SNS), a move that Emergent BioSolutions, Inc., said shows the government’s intent to maintain an... Read More »
The U.S. Food and Drug Administration (FDA) completed its Pre-Approval Inspection (PAI) of Emergent BioSolutions, Inc.’s Building 55 for the large-scale manufacturing of BioThrax (anthrax vaccine adsorbed).
Following the PAI’s conclusion, Emergent BioSolutions received a No Action Indicated... Read More »
The Defense Information Systems Agency’s (DISA) Defense Spectrum Organization (DSO) named Alion Science and Technology on Wednesday as an awardee of a five-year, multiple-award contract valued up to $137 million to assist the military’s access to wireless spectrum frequencies.
Alion will... Read More »
Emergent BioSolutions, Inc.’s supplemental Biologics License Application (sBLA) seeking approval for the manufacture of BioThrax (anthrax vaccine adsorbed) at the company’s Building 55 was accepted for review by the U.S. Food and Drug Administration (FDA) this week.
“Emergent’s... Read More »
